AnaptysBio (AN6) Stock Forecast & Price Target

0 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

AN6 Analyst Ratings

Strong Buy

7 Buy

0 Hold

0 Sell

Based on 7 analysts giving stock ratings to

AnaptysBio

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

AN6 Stock 12 Month Forecast

Average Price Target

€70.62

▲(42.13% Upside)

Based on 7 Wall Street analysts offering 12 month price targets for AnaptysBio in the last 3 months. The average price target is €70.62 with a high forecast of €83.86 and a low forecast of €52.97. The average price target represents a 42.13% change from the last price of €49.69.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"16":"€16","33":"€33","50":"€50","67":"€67","84":"€84"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":83.86410475,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">€83.86</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":70.622404,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">€70.62</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":52.966803,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">€52.97</span>\n  </div></div>","useHTML":true}}],"tickPositions":[16,33,50,67,84],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jan<br/>2026","6":"Apr<br/>2026","9":"Jul<br/>2026","12":"Oct<br/>2026","25":"Oct<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,44.36,47.39877728846154,50.43755457692308,53.476331865384616,56.515109153846154,59.55388644230769,62.59266373076923,65.63144101923076,68.67021830769231,71.70899559615384,74.74777288461539,77.78655017307692,80.82532746153845,{"y":83.86410475,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,44.36,46.380184923076925,48.40036984615384,50.42055476923077,52.440739692307694,54.46092461538461,56.48110953846154,58.501294461538464,60.52147938461539,62.54166430769231,64.56184923076924,66.58203415384615,68.60221907692308,{"y":70.622404,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,44.36,45.02206176923077,45.684123538461535,46.34618530769231,47.00824707692308,47.670308846153844,48.33237061538461,48.994432384615386,49.656494153846154,50.31855592307692,50.98061769230769,51.642679461538464,52.30474123076923,{"y":52.966803,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":17.743,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 25,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":20.613,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 28,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":23.222,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 25,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":28.049,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":27.788,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":30.398,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":31.572,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":56.08,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 24,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":45.68,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":57.74,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":45.67,"date":1785542400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":47.54,"date":1788220800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":44.36,"date":1790812800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target€83.86

Average Price Target€70.62

Lowest Price Target€52.97

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Anupam Rama

J.P. Morgan

€61.79→€52.97

Buy

6.59%

Upside

Assigned

09/30/26

AnaptysBio price target lowered to $60 from $70 at JPMorganAnaptysBio price target lowered to $60 from $70 at JPMorgan

David Risinger

Leerink Partners

€79.45→€71.51

Buy

43.90%

Upside

Reiterated

09/23/26

Wall Street Analysts Are Bullish on Top Healthcare Picks

Etzer Darout

Barclays

€66.21

Buy

33.24%

Upside

Reiterated

09/22/26

Analysts Offer Insights on Healthcare Companies: Quest Diagnostics (NYSE: DGX), AnaptysBio (NASDAQ: ANAB) and Vertex Pharmaceuticals (NASDAQ: VRTX)

Joseph Pantginis

H.C. Wainwright

€83.86

Buy

68.77%

Upside

Reiterated

09/22/26

Analysts' Opinions Are Mixed on These Healthcare Stocks: AnaptysBio (NASDAQ: ANAB), Alkermes (NASDAQ: ALKS) and Iradimed (NASDAQ: IRMD)

Michael Yee

UBS

€67.09

Buy

35.02%

Upside

Assigned

09/22/26

Analysts Conflicted on These Healthcare Names: Alcon (NYSE: ALC), Xenon (NASDAQ: XENE) and AnaptysBio (NASDAQ: ANAB)

Joseph Thome

TD Cowen

―

Buy

―

Assigned

08/25/26

Analysts Offer Insights on Healthcare Companies: Elanco Animal Health (NYSE: ELAN) and AnaptysBio (NASDAQ: ANAB)

Yasmeen Rahimi

Piper Sandler

€82.1

Buy

65.22%

Upside

Reiterated

07/21/26

David Nierengarten

Wedbush

€52.97→€66.21

Buy

33.24%

Upside

Reiterated

03/31/26

Wedbush Remains a Buy on AnaptysBio (ANAB)

Joon Lee

Truist Financial

€31.78→€44.14

Hold

-11.17%

Downside

Reiterated

03/09/26

Truist Financial Keeps Their Hold Rating on AnaptysBio (ANAB)

Yatin Suneja

Guggenheim

€123.59

Buy

148.72%

Upside

Reiterated

03/04/26

Guggenheim Reaffirms Their Buy Rating on AnaptysBio (ANAB)

Derek Archila

Wells Fargo

€71.51

Buy

43.90%

Upside

Reiterated

12/16/25

AnaptysBio (ANAB) Receives a Buy from Wells Fargo

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Anupam Rama

J.P. Morgan

€61.79→€52.97

Buy

6.59%

Upside

Assigned

09/30/26

AnaptysBio price target lowered to $60 from $70 at JPMorganAnaptysBio price target lowered to $60 from $70 at JPMorgan

David Risinger

Leerink Partners

€79.45→€71.51

Buy

43.90%

Upside

Reiterated

09/23/26

Wall Street Analysts Are Bullish on Top Healthcare Picks

Etzer Darout

Barclays

€66.21

Buy

33.24%

Upside

Reiterated

09/22/26

Analysts Offer Insights on Healthcare Companies: Quest Diagnostics (NYSE: DGX), AnaptysBio (NASDAQ: ANAB) and Vertex Pharmaceuticals (NASDAQ: VRTX)

Joseph Pantginis

H.C. Wainwright

€83.86

Buy

68.77%

Upside

Reiterated

09/22/26

Analysts' Opinions Are Mixed on These Healthcare Stocks: AnaptysBio (NASDAQ: ANAB), Alkermes (NASDAQ: ALKS) and Iradimed (NASDAQ: IRMD)

Michael Yee

UBS

€67.09

Buy

35.02%

Upside

Assigned

09/22/26

Analysts Conflicted on These Healthcare Names: Alcon (NYSE: ALC), Xenon (NASDAQ: XENE) and AnaptysBio (NASDAQ: ANAB)

Joseph Thome

TD Cowen

―

Buy

―

Assigned

08/25/26

Analysts Offer Insights on Healthcare Companies: Elanco Animal Health (NYSE: ELAN) and AnaptysBio (NASDAQ: ANAB)

Yasmeen Rahimi

Piper Sandler

€82.1

Buy

65.22%

Upside

Reiterated

07/21/26

David Nierengarten

Wedbush

€52.97→€66.21

Buy

33.24%

Upside

Reiterated

03/31/26

Wedbush Remains a Buy on AnaptysBio (ANAB)

Joon Lee

Truist Financial

€31.78→€44.14

Hold

-11.17%

Downside

Reiterated

03/09/26

Truist Financial Keeps Their Hold Rating on AnaptysBio (ANAB)

Yatin Suneja

Guggenheim

€123.59

Buy

148.72%

Upside

Reiterated

03/04/26

Guggenheim Reaffirms Their Buy Rating on AnaptysBio (ANAB)

Derek Archila

Wells Fargo

€71.51

Buy

43.90%

Upside

Reiterated

12/16/25

AnaptysBio (ANAB) Receives a Buy from Wells Fargo

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

OMCLOmnicell

KNSAKiniksa Pharmaceuticals

ACHVAchieve Life Sciences

AHCOAdaptHealth

ZVRAZevra Therapeutics

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering AnaptysBio

3 Months

Anupam RamaJ.P. Morgan

Success Rate

11/16 ratings generated profit

Average Return

+22.82%

Copying Anupam Rama's trades and holding each position for 3 Months would result in 68.75% of your transactions generating a profit, with an average return of +22.82% per trade.

1 Year

Anupam RamaJ.P. Morgan

Success Rate

12/16 ratings generated profit

Average Return

+107.46%

Copying Anupam Rama's trades and holding each position for 1 Year would result in 75.00% of your transactions generating a profit, with an average return of +107.46% per trade.

2 Years

Derek ArchilaWells Fargo

Success Rate

13/13 ratings generated profit

Average Return

+236.75%

Copying Derek Archila's trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +236.75% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

AN6 Analyst Recommendation Trends

Rating

Jun 26

Jul 26

Aug 26

Sep 26

Oct 26

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, AN6 has received 10 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. AN6 average Analyst price target in the past 3 months is 70.62.

Each month's total comprises the sum of three months' worth of ratings.

AN6 Financial Forecast

AN6 Earnings Forecast

Next quarter’s earnings estimate for AN6 is -€1.62 with a range of -€1.62 to -€1.62. The previous quarter’s EPS was €0.93. AN6 beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate ― of the time in the same period. In the last calendar year AN6 has its overall industry.

AN6 Sales Forecast

Next quarter’s sales forecast for AN6 is €22.56M with a range of €22.56M to €22.56M. The previous quarter’s sales results were €24.27M. AN6 beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates ― of the time in the same period. In the last calendar year AN6 has its overall industry.

AN6 Stock Forecast FAQ

What is DE:AN6’s average 12-month price target, according to analysts?

Based on analyst ratings, AnaptysBio Inc’s 12-month average price target is 70.62.

What is DE:AN6’s upside potential, based on the analysts’ average price target?

AnaptysBio Inc has 42.13% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is AnaptysBio Inc a Buy, Sell or Hold?

AnaptysBio Inc has a consensus rating of Strong Buy, which is based on 7 buy ratings, 0 hold ratings and 0 sell ratings.

What is AnaptysBio Inc’s share price target?

The average share price target for AnaptysBio Inc is 70.62. This is based on 7 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is €83.86 ,and the lowest forecast is €52.97. The average share price target represents 42.13% Increase from the current price of €49.69.

What do analysts say about AnaptysBio Inc?

AnaptysBio Inc’s analyst rating consensus is a Strong Buy. This is based on the ratings of 7 Wall Streets Analysts.

How can I buy shares of AnaptysBio Inc?

To buy shares of DE:AN6, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.

AnaptysBio (AN6) Stock Forecast & Price Target

AN6 Analyst Ratings

AN6 Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering AnaptysBio

AN6 Analyst Recommendation Trends

AN6 Financial Forecast

AN6 Earnings Forecast

AN6 Sales Forecast

AN6 Stock Forecast FAQ

Detailed List of Analyst Forecasts